Kun-he Q. Zhang

No 17, Yongwai Zheng Street
Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

A Clinlabomics-Based Machine Learning Model Accurately Differentiates Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesion.

A Clinlabomics-Based Machine Learning Model Accurately Differentiates Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesion.

Journal: Journal of hepatocellular carcinoma

Published: January 31, 2026

An interpretable machine learning model using routine clinical data for early recurrence prediction in hepatocellular carcinoma.

An interpretable machine learning model using routine clinical data for early recurrence prediction in hepatocellular carcinoma.

Journal: Scientific reports

Published: July 23, 2025

Comprehensive analysis of zinc finger protein 367 as a potential pan-cancer diagnostic and prognostic biomarker and underlying biological mechanisms.

Comprehensive analysis of zinc finger protein 367 as a potential pan-cancer diagnostic and prognostic biomarker and underlying biological mechanisms.

Journal: Discover oncology

Published: June 13, 2025

Dual tissue mRNA and serum protein signatures improve risk stratification in hepatocellular carcinoma.

Dual tissue mRNA and serum protein signatures improve risk stratification in hepatocellular carcinoma.

Journal: NPJ precision oncology

Published: June 03, 2025

Research Trends on Nanomaterials and Hepatocellular Carcinoma From 1999 to 2024: A Bibliometric Analysis.

Research Trends on Nanomaterials and Hepatocellular Carcinoma From 1999 to 2024: A Bibliometric Analysis.

Journal: Drug design, development and therapy

Published: January 09, 2025

ILF2 protein is a promising serum biomarker for early detection of gastric cancer.

ILF2 protein is a promising serum biomarker for early detection of gastric cancer.

Journal: BMC cancer

Published: August 26, 2024

Trends and frontiers in signal amplification for aptamer-based tumor detection: A bibliometric analysis.

Trends and frontiers in signal amplification for aptamer-based tumor detection: A bibliometric analysis.

Journal: World journal of clinical cases

Published: March 29, 2024

Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.

Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.

Journal: BMC cancer

Published: January 26, 2024

The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions.

The Index sAGP is Valuable for Distinguishing Atypical Hepatocellular Carcinoma from Atypical Benign Focal Hepatic Lesions.

Journal: Journal of hepatocellular carcinoma

Published: December 04, 2023

Evolution and Trends of Aptamers in Cancer Research: A Bibliometric Analysis of the Literature over the Last Decade.

Evolution and Trends of Aptamers in Cancer Research: A Bibliometric Analysis of the Literature over the Last Decade.

Journal: Current medicinal chemistry

Published: October 22, 2023

Bibliometric analysis of aptamer-conjugated nanoparticles for diagnosis in the last two decades.

Bibliometric analysis of aptamer-conjugated nanoparticles for diagnosis in the last two decades.

Journal: Nanotechnology

Published: August 05, 2023

Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms.

Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms.

Journal: Journal of cancer research and clinical oncology

Published: April 25, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026